CME Group Inc. (CME) trades at a trailing P/E of 26.6, forward P/E of 24.3. Trailing earnings yield is 3.76%, forward earnings yield 4.12%. PEG 1.73. Graham Number is $142.17.
Criteria proven by this page:
Overall SharesGrow Score: 75/100 with 5/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 25.4 | 1.12 | 1.91 | 10.83 | 4.59% |
| 2017 | 12.2 | 0.07 | 2.21 | 13.57 | 4.03% |
| 2018 | 32.8 | -0.63 | 2.48 | 14.94 | 3.34% |
| 2019 | 33.9 | 9.70 | 2.74 | 14.73 | 2.37% |
| 2020 | 30.9 | -36.69 | 2.47 | 13.34 | 3.24% |
| 2021 | 31.1 | 1.29 | 2.99 | 17.46 | 2.67% |
| 2022 | 22.4 | 14.88 | 2.24 | 12.02 | 4.37% |
| 2023 | 23.4 | 1.19 | 2.83 | 13.55 | 4.28% |
| 2024 | 23.7 | 2.56 | 3.15 | 13.61 | 4.29% |
| 2025 | 24.3 | 1.58 | 3.42 | 15.06 | 4.00% |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $4.53 | $3.6B | $1.53B | 42.7% |
| 2017 | $11.94 | $3.64B | $4.06B | 111.5% |
| 2018 | $5.71 | $4.31B | $1.96B | 45.5% |
| 2019 | $5.91 | $4.87B | $2.12B | 43.5% |
| 2020 | $5.87 | $4.88B | $2.11B | 43.1% |
| 2021 | $7.29 | $4.69B | $2.64B | 56.2% |
| 2022 | $7.40 | $5.02B | $2.69B | 53.6% |
| 2023 | $8.86 | $5.58B | $3.23B | 57.8% |
| 2024 | $9.67 | $6.13B | $3.53B | 57.5% |
| 2025 | $11.16 | $6.52B | $4.04B | 62% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $12.04 | $11.58 – $13.10 | $7B | $6.82B – $7.38B | 8 |
| 2027 | $12.71 | $11.54 – $13.69 | $7.33B | $6.99B – $7.87B | 9 |
| 2028 | $13.78 | $12.82 – $14.71 | $7.87B | $7.8B – $7.94B | 3 |
| 2029 | $15.04 | $14.30 – $16.21 | $8.35B | $8.04B – $8.85B | 1 |
| 2030 | $14.09 | $13.40 – $15.19 | $8.42B | $8.1B – $8.92B | 1 |
